960289-06-9

Upstream product

• 960400-58-2 5-chloro-thiophene-2-carboxylic acid (2,2-diethoxyethyl)amide 
• 1679-18-1 4-Chlorophenylboronic acid 
• 24065-33-6 5-Chlorothiophene-2-carboxylic acid 
• 645-36-3 2,2-diethoxy-ethanamine 

Downstream Products

• 960289-07-0 5-(4-chlorophenyl)-thiophene-2-carboxylic acid (2-oxoethyl)amide 
• 960289-27-4 2-(4-chloro-phenyl)-6H-thieno[2,3-c]pyridin-7-one 
• 960402-40-8 6-(4-bromo-phenyl)-2-(4-chloro-phenyl)-6H-thieno[2,3-c]pyridin-7-one 
• 960402-73-7 (+/-)-pyrrolidine-3-carboxylic acid {4-[2-(4-chloro-phenyl)-7-oxo-7H-thieno[2,3-c]pyridin-6-yl]-phenyl}-amide 
• 960402-65-7 (+/-)-3-{4-[2-(4-chloro-phenyl)-7-oxo-7H-thieno[2,3-c]pyridin-6-yl]-phenylcarbamoyl}-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 960402-67-9 (+/-)-2-(4-chloro-phenyl)-6-[3-methoxy-4-(pyrrolidine-3-carbonyl)-phenyl]-6H-thieno[2,3-c]pyridin-7-one trifluoroacetic acid 

Relevant academic research and scientific papers

NOVEL MCH RECEPTOR ANTAGONISTS

The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.

NOVEL MCH RECEPTOR ANTAGONISTS

The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.